posted on
Oct 10, 2008 12:17PM
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: Q is out
August 31, 2008
|
August 31, 2007
|
|||||||
Revenues
|
||||||||
Product sales and other
|
$ | 1,358,646 | $ | 521,369 | ||||
Cost of sales
|
584,253 | 151,535 | ||||||
Gross profit
|
774,393 | 369,834 | ||||||
Operating expenses:
|
||||||||
Selling, general and administrative
|
1,930,805 | 1,958,190 | ||||||
Settlement and license expense
|
- | 30,000 | ||||||
Total operating expenses
|
1,930,805 | 1,988,190 | ||||||
Operating loss
|
(1,156,412 | ) | (1,618,356 | ) | ||||
Other income (expense):
|
||||||||
Interest and other income
|
112,846 | 474,525 | ||||||
Loss on sale of assets
|
- | (345 | ) | |||||
Interest expense
|
(4,622 | ) | (237 | ) | ||||
Gain on sale of subsidiary interest
|
- | 150,000 | ||||||
Equity in earnings (loss) of affiliated companies
|
6,558,770 | (1,200,542 | ) | |||||
Total other income (expense), net
|
6,666,994 | (576,599 | ) | |||||
Income (loss) before income taxes and minority interest
|
5,510,582 | (2,194,955 | ) | |||||
Provision (benefit) for income taxes
|
2,379,705 | (232,569 | ) | |||||
Minority interest
|
(78,636 | ) | - | |||||
Net income (loss)
|
$ | 3,209,513 | $ | (1,962,386 | ) | |||
Basic income (loss) per common share
|
$ | 0.01 | $ | (0.01 | ) | |||
Diluted income (loss) per common share
|
$ | 0.01 | $ | (0 |
1 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply